Heart disease remains one of the leading causes of death around the world. In many Western countries, conditions linked to heart and blood vessel problems cause a large number of deaths each year.
One of the most common forms of heart disease is a condition called atherosclerosis. This disease develops slowly over many years as fatty deposits build up inside the arteries, the blood vessels that carry oxygen-rich blood from the heart to the rest of the body.
These fatty deposits are often called plaques. They are made from cholesterol, fats, calcium, and other materials circulating in the bloodstream.
As plaques grow larger, they can narrow the arteries and make it harder for blood to flow. If a plaque suddenly breaks open, it can lead to the formation of a blood clot that blocks the artery. This blockage can cause a heart attack or a stroke.
For decades, scientists have focused on cholesterol as a main cause of atherosclerosis. This idea is often called the “lipid hypothesis.”
According to this view, high levels of cholesterol in the blood lead to plaque buildup inside arteries. Cholesterol-lowering medicines such as statins have helped reduce the risk of heart disease for many people, which supports the importance of cholesterol in the process.
However, scientists have also realized that cholesterol alone does not explain everything about heart disease. Inflammation, which is the body’s response to injury or infection, also plays a key role. When inflammation occurs in blood vessels, it can damage the vessel walls and promote the growth of plaques.
A new study from researchers at New York University has revealed another surprising factor involved in this process. The research shows that platelets, tiny cell fragments in the blood that are best known for helping stop bleeding, may also play an important role in driving inflammation in arteries.
Platelets are very small pieces of cells that circulate in the bloodstream. Their main job is to help the body form blood clots when a person is injured. When a blood vessel is damaged, platelets quickly gather at the site of the injury and stick together to stop the bleeding.
Because of this function, platelets have long been associated mainly with clotting and wound repair. However, scientists have recently begun to discover that platelets also interact with the immune system in complex ways.
In the new study, researchers led by Dr. Tessa Barrett at New York University investigated how platelets might contribute to the development of atherosclerosis. Their findings were published in the scientific journal Science Translational Medicine.
The team found that when platelets become activated, they release signals that promote inflammation. These signals attract immune cells, including white blood cells called leukocytes, to the walls of blood vessels.
Once these immune cells arrive, they stick to the vessel walls and move into the surrounding tissue. This process increases inflammation inside the artery and contributes to the buildup of plaques.
One of the most important discoveries in the study involved a protein called SOCS3, which stands for Suppressor of Cytokine Signaling 3. This protein helps control how immune cells respond to inflammatory signals.
The researchers found that platelets influence the activity of SOCS3 in immune cells. When platelet activity increases, it changes how SOCS3 functions, which can accelerate inflammation and encourage plaque formation in the arteries.
The team also studied blood samples and tissue from people with cardiovascular disease. They found higher levels of platelet activity and increased SOCS3 signaling in patients who had atherosclerosis. These changes were also observed in women who had experienced heart attacks and in people with blocked arteries in their legs.
Another surprising finding was that platelets appeared to contribute to artery inflammation even when they were not forming blood clots. This means that platelets may worsen heart disease through inflammation alone, separate from their well-known role in clotting.
This discovery helps scientists understand a missing link in the development of heart disease. It shows how platelet activity, immune responses, and inflammation work together to damage arteries and promote plaque buildup.
The findings suggest that platelets may be doing far more than previously thought. Instead of simply stopping bleeding, they may also help trigger inflammatory processes that gradually damage blood vessels.
Understanding this hidden role of platelets could open new possibilities for treating heart disease. If scientists can develop treatments that reduce the inflammatory signals released by platelets, it might be possible to slow down or prevent the development of atherosclerosis.
Current heart disease treatments often focus on lowering cholesterol levels. While these therapies remain important, the new research suggests that targeting inflammation could provide another powerful way to protect the heart.
By revealing the connection between platelets, immune cells, and the SOCS3 protein, the study expands our understanding of how heart disease develops. It also highlights the complex interactions that occur inside blood vessels over many years before symptoms appear.
The research led by Dr. Tessa Barrett at New York University and published in Science Translational Medicine provides an important step forward in uncovering these hidden processes. Scientists hope that future studies will build on these findings and lead to new treatments that better control inflammation in the arteries.
Such advances could ultimately help reduce the number of heart attacks and strokes and improve the long-term health of millions of people around the world.
If you care about heart disease, please read studies that herbal supplements could harm your heart rhythm, and how eating eggs can help reduce heart disease risk.
For more health information, please see recent studies that apple juice could benefit your heart health, and results showing yogurt may help lower the death risks in heart disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
